LFM A13

BTK kinase inhibitor

Catalog No. SIH-461

0 out of 5 based on 0 customer ratings
CAS No. 62004-35-7
Molecular Formula C11H8Br2N2O2
SKU: SIH-461 Categories: ,

Clear
SIH-461_LFM-A13_Chemical_Structure.png
Product Name LFM A13
Description

BTK kinase inhibitor

Purity >97% (TLC)
CAS No. 62004-35-7
Molecular Formula C11H8Br2N2O2
Molecular Weight 360.0
Field of Use Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

Properties

Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in DMSO (10 mg/ml) or ethanol (0.3 mg/ml)
Source Synthetic
Appearance Yellow solid
SMILES C/C(=C(C#N)/C(=O)NC1=C(C=CC(=C1)Br)Br)/O
InChI InChI=1S/C11H8Br2N2O2/c1-6(16)8(5-14)11(17)15-10-4-7(12)2-3-9(10)13/h2-4,16H,1H3,(H,15,17)
InChIKey UVSVTDVJQAJIFG-UHFFFAOYSA-N
Safety Phrases Classification:
Not a hazardous substance or mixture.

Safety Phrases:
S22 - Do not breathe dust.
S24/25 - Avoid contact with skin and eyes.
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
Cite This Product LFM A13 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-461)

Biological Description

Alternative Names 2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide
Research Areas Apoptosis, Cancer, Cancer Growth Inhibitors, Cell Signaling, Tyrosine Kinase Inhibitors
PubChem ID 54686938
Scientific Background LFM A13 is a potent and selective inhibitor of Bruton's tyrosine kinase (BTK).
References 1. Vassilev A., Ozer Z., Navara C., Mahajan S., & Uckun F.M. (1999). J. Biol. Chem. 274(3): 1646–1656.

Product Images

<p>Chemical structure of LFM A13 (SIH-461), a BTK kinase inhibitor. CAS #: 62004-35-7. Molecular Formula: C11H8Br2N2O2. Molecular Weight: 360 g/mol.</p>

Chemical structure of LFM A13 (SIH-461), a BTK kinase inhibitor. CAS #: 62004-35-7. Molecular Formula: C11H8Br2N2O2. Molecular Weight: 360 g/mol.

Reviews

Reviews

There are no reviews yet.

Be the first to review “LFM A13”

Your email address will not be published. Required fields are marked *